The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be
| Study Name on ClinicalTrials.gov (link is external) | A study of safety, tolerability and effect of SNSP113 in Cystic Fibrosis |
|---|---|
| Study Drug | SNSP113 |
| Type of Study Drug | Anti-infective |
| Study Title | A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Effect of Inhaled SNSP113 in Adult Subjects with Cystic Fibrosis |
| Study Phase | 2 |
| Study Sponsor | Synspira |
https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-003178-25/HU | |
| Participating ECFS-CTN sites | Please contact ecfs-ctn@uzleuven.be for most recent sitelist |
| Age | 18 Years and older |